Journal List > J Korean Ophthalmol Soc > v.49(8) > 1008039

Kim, Yoo, Ha, Kim, Lee, Kim, Jee Youn, and Kim: Evaluation of Sensitivity and Specificity of DNA Chip for Diagnosis of Granular Corneal Dystrophy II

Abstract

Purpose

To evaluate the sensitivity and specificity of the DNA chip method in diagnosing patients with granular corneal dystrophy type II (GCD II) induced by mutation of the β igh3 gene.

Methods

Two hundred twenty-seven patients who visited Severance Eye hospital, corneal dystrophy clinic, from 1 July 2006 to 30 September 2007 were included in this study after history taking and review of their medical records. All subjects were examined by slit lamp microscopy, and blood sampling was done. The sampled blood was used in DNA sequencing and the DNA chip method.

Results

Among 227 subjects, 125 (54.6%) patients had GCD II and 103 (45.4%) patients showed normal results according to the DNA sequencing method. The sensitivity and specificity of the DNA chip method were both 100%, while the sensitivity of the slit lamp method was 99.19% and the specificity was 100%.

Conclusions

The DNA chip method for diagnosing GCD II is a more simple, time-saving, and accurate method than DNA sequencing method, and the sensitivity and specificity were both 100%.

References

1. Afshari NA, Mullally JE, Afshari MA. . Survey of patients with granular, lattice, avellino, and Reis-Bucklers corneal dystrophies for mutations in the BIGH3 and gelsolin genes. Arch Ophthalmol. 2001; 119:16–22.
2. Chau HM, Ha NT, Cung LX. . H626R and R124C mutations of the TGFBI (BIGH3) gene caused lattice corneal dystrophy in Vietnamese people. Br J Ophthalmol. 2003; 87:686–9.
crossref
3. Ellies P, Renard G, Valleix S. . Clinical outcome of eight BIGH3-linked corneal dystrophies. Ophthalmology. 2002; 109:793–7.
crossref
4. Hellenbroich Y, Tzivras G, Neppert B. . R124C mutation of the ßIGH3 gene leads to remarkable phenotypic variability in a Greek four-generation family with lattice corneal dystrophy type 1. Ophthalmologica. 2001; 215:444–7.
crossref
5. Schmitt-Bernard CF, Chavanieu A, Derancourt J. . In vitro creation of amyloid fibrils from native and Arg124Cys mutated betaIGH3((110-131)) peptides, and its relevance for lattice corneal amyloid dystrophy type I. Biochem Biophys Res Commun. 2000; 273:649–53.
6. Ferry AP, Benson WH, Weinberg RS. Combined granularlattice (Avellino) corneal dystrophy. Trans Am Ophthalmol Soc. 1997; 95:61–77.
7. Moon JW, Kim SW, Kim TI. . Homozygous granular corneal dystrophy type II (Avellino corneal dystrophy) natural history and progression after treatment. Cornea. 2007; 26:1095–100.
8. Holland EJ, Daya SM, Stone EM. . Avellino corneal dystrophy: clinical manifestations and natural history. Ophthalmology. 1992; 99:1564–8.
9. Jun RM, Tchah H, Kim TI. . Avellino corneal dystrophy after LASIK. Ophthalmology. 2004; 111:463–8.
crossref
10. Wan XH, Lee HC, Stulting RD. . Exacerbation of Avellino corneal dystrophy after laser in situ keratomileusis. Cornea. 2002; 21:223–6.
crossref
11. Roh MI, Grossniklaus HE, Chung SH. . Avellino corneal dystrophy exacerbated after LASIK scanning electron microscopic findings. Cornea. 2006; 25:306–11.
12. Banning CS, Kim WC, Randleman JB. . Exacerbation of Avellino corneal dystrophy after LASIK in north America. Cornea. 2006; 25:482–4.
crossref
13. Wan XH, Lee HC, Stulting RD. . Exacerbation of Avellino corneal dystrophy after laser in situ keratomileusis. Cornea. 2002; 21:223–6.
crossref
14. El-Ashry MF, Abd El-Aziz MM, Ficker LA. . BIGH3 mutation in a Bangladeshi family with a variable phenotype of LCDI. Eye. 2004; 18:723–8.
crossref
15. Konishi M, Yamada M, Nakamura Y, Mashima Y. Varied appearance of cornea of patients with corneal dystrophy associated with R124H mutation in the BIGH3 gene. Cornea. 1999; 18:424–9.
16. Yoshida S, Yoshida A, Nakao S. . Lattice corneal dystrophy type I without typical lattice lines: role of mutational analysis. Am J Ophthalmol. 2004; 137:586–8.
crossref
17. Mitterer G, Huber M, Leidinger E. . Microarray-based identification of bacteria in clinical samples by solid-phase PCR amplification of 23S ribosomal DNA sequences. J Clin Microbiol. 2004; 42:1048–57.
crossref
18. Siemering K, Manji SS, Hutchison WM. . Detection of mutations in genes associated with hearing loss using a microarray-based approach. J Mol Diagn. 2006; 8:483–9.
crossref
19. Yoo SY, Kim TI, Lee SY. . Development of a DNA chip for the diagnosis of the most common corneal dystrophies caused by mutations in the betaigh3 gene. Br J Ophthalmol. 2007; 91:722–7.
20. Yamamoto S, Okada M, Tsujikawa M. . The spectrum of beta ig-h3 gene mutations in Japanese patients with corneal dystrophy. Cornea. 2000; May. 19:S21–3.
21. Rosenwasser GO, Sucheski BM, Rosa N. . Phenotypic variation in combined granular-lattice (Avellino) corneal dystrophy. Arch Ophthalmol. 1993; 111:1546–52.
crossref

tables

Table 1.
Demographic features of the patients
Cornea dystrophy N (%) Normal N (%) Total N (%)
Sex
Male 40 (32.26) 43 (41.75) 83 (36.56)
Female 84 (67.74) 60 (58.25) 144 (63.44)
Age
-10 4 (3.23) 2 (1.94) 6 (2.64)
11-20 12 (9.68) 11 (10.68) 23 (10.13)
21-30 34 (27.42) 21 (20.39) 55 (24.23)
31-40 20 (16.13) 24 (23.30) 44 (19.38)
41-50 18 (14.52) 19 (18.45) 37 (16.30)
51-60 21 (16.94) 16 (15.53) 37 (16.30)
60-70 10 (8.06) 6 (5.83) 16 (7.05)
71-80 4 (3.23) 3 (2.91) 7 (3.08)
80- 1 (0.81) 1 (0.97) 2 (0.88)
Mean±SD 37.78±17.12 38.08±16.03 37.92±16.60
Systemic disease*
More than one 24 (19.35) 15 (14.56) 39 (17.18)
None 100 (80.65) 88 (85.44) 188 (82.82)
Total 124 (54.63) 103 (45.37) 227 (100.00)

* Hypertension, angina, hyperlipidemia.

Table 2.
Sensitivity and specificity of slit lamp exam method
Dignosed by slit lamp

Normal ACD, heterozygote ACD, homozygote Total Sensitivity of slit lamp method (%)
Diagnosis*
Normal 103 0 0 103
ACD, heterozygote ACD, homozygote 10 119 0 0 4 120 4 99.19
Total 104 119 4 227
Specificity of slit lamp method (%) 100.0

* Diagnosed by DNA sequencing method;

Diagnoded by slit lamp biomicroscopic findings

Avellino corneal dystrophy.

Table 3.
Sensitivity and specificity of DNA chip
Diagnosed by DNA chip
Normal ACD, heterozygote ACD, homozygote Total Sensitivity of DNA chip method (%)
Diagnosis*
Normal 103 0 0 103
ACD, heterozygote 0 120 0 120 100.0
ACD, homozygote 0 0 4 4
Total 103 120 4 227
Specificity of DNA chip method (%) 100.0

* Diagnosed by DNA sequencing method;

Diagnoded by DNA chip method.

TOOLS
Similar articles